Rapidly e ective, with clinical improvements within 3 days of starting therapy:@0.066865:0.677748:0.480908:0.677748:0.480908:0.662546:0.066865:0.662546:0.002637:0.011171:0.006988:0.006115:0.006703:0.003091:0.006703:0.003209:0.005812:0.002637:0.006098:0.003763:0.003763:0.006098:0.005325:0.004284:0.003091:0.005611:0.005930:0.003259:0.002637:0.009508:0.003091:0.004284:0.006804:0.002637:0.005073:0.003209:0.003091:0.006804:0.003091:0.005124:0.006115:0.003209:0.002637:0.003091:0.010415:0.006703:0.003931:0.006316:0.005611:0.006098:0.010415:0.006098:0.006703:0.004284:0.004855:0.002637:0.009508:0.003091:0.004284:0.006804:0.003091:0.006804:0.002637:0.006468:0.002637:0.006703:0.005947:0.005812:0.004855:0.002637:0.006434:0.003830:0.002637:0.004855:0.004284:0.006115:0.004569:0.004284:0.003091:0.006804:0.006703:0.002637:0.004284:0.006804:0.006098:0.004065:0.006115:0.006585:0.005812
4:@0.480900:0.672139:0.484670:0.672139:0.484670:0.663276:0.480900:0.663276:0.003771
Progressive :@0.080675:0.700415:0.150625:0.700415:0.150625:0.684918:0.080675:0.684918:0.007677:0.004872:0.007240:0.007509:0.004872:0.007039:0.005443:0.005443:0.003746:0.006400:0.007039:0.002671
increase in e  cacy that is sustained long-term*:@0.150625:0.700415:0.395503:0.700415:0.395503:0.685213:0.150625:0.685213:0.003091:0.006804:0.005073:0.003931:0.006098:0.006115:0.004855:0.006098:0.002637:0.003091:0.006804:0.002637:0.006098:0.003612:0.003612:0.003612:0.005124:0.006115:0.005409:0.005812:0.002637:0.004284:0.006804:0.005964:0.004284:0.002637:0.003091:0.004855:0.002637:0.004855:0.006686:0.004855:0.004284:0.006115:0.003091:0.006804:0.006098:0.006703:0.002637:0.003209:0.006434:0.006804:0.006703:0.004687:0.004149:0.006098:0.004166:0.010415:0.006266
4:@0.395496:0.694805:0.399266:0.694805:0.399266:0.685943:0.395496:0.685943:0.003771
Proactive:@0.080675:0.723081:0.135708:0.723081:0.135708:0.707585:0.080675:0.707585:0.007677:0.004872:0.007240:0.007089:0.005745:0.005224:0.003746:0.006400:0.007039
 management with PROTOPIC® may overcome limitations associated :@0.135708:0.723081:0.489964:0.723081:0.489964:0.707880:0.135708:0.707880:0.002637:0.010415:0.006115:0.006804:0.006115:0.006703:0.006098:0.010415:0.006098:0.006703:0.004284:0.002637:0.009508:0.003091:0.004284:0.006804:0.002805:0.007039:0.007207:0.007425:0.005745:0.007828:0.007039:0.003679:0.006434:0.006249:0.002637:0.010415:0.005947:0.005812:0.002637:0.006316:0.005611:0.006098:0.003931:0.004972:0.006434:0.010415:0.006098:0.002637:0.003209:0.003091:0.010415:0.003091:0.004284:0.005964:0.004284:0.003091:0.006434:0.006804:0.004855:0.002637:0.006115:0.004855:0.004855:0.006434:0.005073:0.003091:0.005964:0.004149:0.006098:0.006703:0.002637
with long-term topical steroid use:@0.080675:0.738475:0.255299:0.738475:0.255299:0.723274:0.080675:0.723274:0.009508:0.003091:0.004284:0.006804:0.002637:0.003209:0.006434:0.006804:0.006703:0.004687:0.004149:0.006098:0.004166:0.010415:0.002637:0.004149:0.006434:0.006703:0.003091:0.005124:0.006115:0.003209:0.002637:0.004855:0.004149:0.006098:0.003931:0.006434:0.003091:0.006703:0.002637:0.006686:0.004855:0.006098
 5:@0.255295:0.732866:0.259624:0.732866:0.259624:0.724003:0.255295:0.724003:0.000558:0.003771
Protective:@0.080675:0.761142:0.140781:0.761142:0.140781:0.745645:0.080675:0.745645:0.007677:0.004872:0.007240:0.005124:0.007039:0.005745:0.005224:0.003746:0.006400:0.007039
 against  ares and topical corticosteroid-related adverse events:@0.140781:0.761142:0.463825:0.761142:0.463825:0.745940:0.140781:0.745940:0.002637:0.006115:0.006703:0.006115:0.003091:0.006804:0.004855:0.004284:0.002637:0.003511:0.003511:0.006115:0.003931:0.006098:0.004855:0.002637:0.006115:0.006804:0.006703:0.002637:0.004149:0.006434:0.006703:0.003091:0.005124:0.006115:0.003209:0.002637:0.004972:0.006434:0.004569:0.004284:0.003091:0.004972:0.006434:0.004855:0.004149:0.006098:0.003931:0.006434:0.003091:0.006703:0.004687:0.003931:0.006098:0.003209:0.005964:0.004149:0.006098:0.006703:0.002637:0.006115:0.006703:0.005611:0.006098:0.004166:0.004855:0.006098:0.002637:0.006098:0.005611:0.006098:0.006703:0.004284:0.004855
 5-9:@0.463815:0.755533:0.475627:0.755533:0.475627:0.746670:0.463815:0.746670:0.001538:0.003771:0.002733:0.003771
Adcock Ingram Limited. Reg. No. 1949/034385/06, Private Bag X69, Bryanston, 2021, South Africa , Telephone + 27 11 635 0000,www.adcock.com:@0.228827:0.970175:0.679707:0.970175:0.679707:0.961054:0.228827:0.961054:0.004284:0.004022:0.002983:0.003860:0.003044:0.003568:0.001582:0.002006:0.004082:0.004022:0.002439:0.003669:0.006249:0.001582:0.003467:0.001855:0.006249:0.001855:0.002490:0.003659:0.003891:0.001955:0.001582:0.004122:0.003659:0.003800:0.001955:0.001582:0.004647:0.003518:0.001955:0.001582:0.003881:0.003881:0.003881:0.003881:0.002832:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.002832:0.003881:0.003881:0.001955:0.001582:0.003961:0.002500:0.001855:0.003407:0.003578:0.002490:0.003659:0.001582:0.004253:0.003669:0.004022:0.001582:0.003951:0.003881:0.003881:0.001955:0.001582:0.004223:0.002762:0.003397:0.003669:0.004082:0.002913:0.002490:0.003860:0.004082:0.001955:0.001582:0.003881:0.003881:0.003881:0.003881:0.001955:0.001582:0.003709:0.003860:0.004012:0.002570:0.004082:0.001582:0.004264:0.002298:0.002500:0.001855:0.003074:0.003669:0.001582:0.001955:0.001230:0.002953:0.003659:0.001925:0.003659:0.004022:0.004082:0.003860:0.004082:0.003659:0.001582:0.006007:0.001582:0.003881:0.003881:0.001582:0.003881:0.003881:0.001582:0.003881:0.003881:0.003881:0.001582:0.003881:0.003881:0.003881:0.003881:0.001955:0.005907:0.005907:0.005272:0.001955:0.003669:0.004022:0.002983:0.003860:0.003044:0.003639:0.001955:0.002983:0.003860:0.006249
LEPETTA 083 415 6431 11314T:@0.044335:0.968251:0.044335:0.899081:0.036332:0.899081:0.036332:0.968251:0.000000:0.000000:0.000000:0.000000:0.000000:0.019460:-0.016700:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.087820
*Protopic maintenance therapy should be applied once a day, twice per week. Continuation of treatment should be reviewed after 12 months:@0.056865:0.807584:0.490277:0.807584:0.490277:0.798463:0.056865:0.798463:0.003760:0.003961:0.002359:0.003860:0.002490:0.003860:0.004022:0.001855:0.003044:0.001582:0.006249:0.003669:0.001855:0.004022:0.002490:0.003659:0.004082:0.003669:0.004082:0.002983:0.003659:0.001582:0.002570:0.004082:0.003659:0.002439:0.003669:0.003951:0.003487:0.001582:0.002913:0.004082:0.003860:0.004012:0.001925:0.004022:0.001582:0.004022:0.003659:0.001582:0.003669:0.004022:0.004022:0.001925:0.001855:0.003659:0.004022:0.001582:0.003860:0.004082:0.002983:0.003659:0.001582:0.003669:0.001582:0.004022:0.003568:0.003054:0.001955:0.001582:0.002671:0.005705:0.001855:0.002983:0.003659:0.001582:0.004022:0.003659:0.002500:0.001582:0.005574:0.003659:0.003659:0.003639:0.001955:0.001582:0.003578:0.003860:0.004022:0.002570:0.001855:0.004082:0.004012:0.003578:0.002570:0.001855:0.003860:0.004082:0.001582:0.003860:0.002298:0.001582:0.002570:0.002359:0.003659:0.003578:0.002570:0.006249:0.003659:0.004022:0.002570:0.001582:0.002913:0.004082:0.003860:0.004012:0.001925:0.004022:0.001582:0.004022:0.003659:0.001582:0.002359:0.003659:0.003498:0.001855:0.003659:0.005574:0.003659:0.004022:0.001582:0.003669:0.002348:0.002490:0.003659:0.002500:0.001582:0.003881:0.003881:0.001582:0.006249:0.003860:0.004022:0.002570:0.004082:0.002913
 1 :@0.490269:0.804219:0.494376:0.804219:0.494376:0.798901:0.490269:0.798901:0.000923:0.002262:0.000923
References: 1.:@0.056865:0.822978:0.106143:0.822978:0.106143:0.813680:0.056865:0.813680:0.004707:0.004223:0.002802:0.004223:0.002923:0.004223:0.004616:0.003256:0.004223:0.003266:0.002348:0.001824:0.004294:0.002348
 PROTOPIC® 0.03 % and 0.1 % ointment package insert. February 2017.   Hani n JM, Paller AS, Eichen eld L, :@0.106143:0.822978:0.449154:0.822978:0.449154:0.813857:0.106143:0.813857:0.001804:0.004122:0.004324:0.004455:0.003447:0.004697:0.004223:0.002207:0.003860:0.003750:0.001804:0.003881:0.001955:0.003881:0.003881:0.001804:0.006501:0.001804:0.003669:0.004082:0.004022:0.001804:0.003881:0.001955:0.003881:0.001804:0.006501:0.001804:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001804:0.004022:0.003669:0.003044:0.003618:0.003669:0.004022:0.003659:0.001804:0.001855:0.004082:0.002913:0.003659:0.002742:0.002439:0.001955:0.001804:0.003276:0.003659:0.004022:0.002469:0.004012:0.003669:0.002762:0.003487:0.001804:0.003881:0.003881:0.003881:0.003881:0.001955:0.001582:0.006864:0.001804:0.004667:0.003669:0.004082:0.001855:0.002107:0.002107:0.004082:0.001804:0.002671:0.006038:0.001955:0.001804:0.003770:0.003669:0.001925:0.001925:0.003659:0.002500:0.001804:0.004385:0.003639:0.001955:0.001804:0.003528:0.001855:0.003044:0.004082:0.003659:0.004082:0.002107:0.002107:0.003659:0.001925:0.004022:0.001804:0.003467:0.001955:0.001582
2.:@0.329955:0.822978:0.336597:0.822978:0.336597:0.813680:0.329955:0.813680:0.004294:0.002348
et al,:@0.449375:0.822978:0.464132:0.822978:0.464132:0.813865:0.449375:0.813865:0.003407:0.002419:0.001683:0.003830:0.001492:0.001925
 for the US Tacrolimus Ointment Study Group. E  cacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad :@0.464132:0.822978:0.963282:0.822978:0.963282:0.813857:0.464132:0.813857:0.001804:0.002268:0.003860:0.002500:0.001804:0.002570:0.004082:0.003659:0.001804:0.004606:0.003639:0.001451:0.003024:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001804:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001804:0.003598:0.002570:0.004012:0.004022:0.003487:0.001804:0.004425:0.002359:0.003860:0.004012:0.003679:0.001955:0.001804:0.003467:0.002167:0.002167:0.002167:0.003074:0.003669:0.003246:0.003487:0.001804:0.003669:0.004082:0.004022:0.001804:0.002913:0.003669:0.002268:0.003659:0.002671:0.003487:0.001804:0.003860:0.002298:0.001804:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001804:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001804:0.002570:0.002359:0.003659:0.003578:0.002570:0.006249:0.003659:0.004022:0.002570:0.001804:0.002268:0.003860:0.002500:0.001804:0.004012:0.004022:0.001804:0.002490:0.003860:0.001804:0.003881:0.001804:0.003356:0.003659:0.003669:0.002500:0.002913:0.001804:0.001855:0.004082:0.001804:0.004022:0.003578:0.002570:0.001855:0.003659:0.004022:0.002570:0.002913:0.001804:0.005705:0.001855:0.002570:0.004082:0.001804:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001804:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002782:0.001955:0.001804:0.002671:0.001804:0.004354:0.006249:0.001804:0.004284:0.003074:0.003669:0.004022:0.001582
Dermatol 2005;53:S186-94.  Wollenberg A, Oranje A, Deleuran M, et al, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad :@0.056865:0.830675:0.963342:0.830675:0.963342:0.821554:0.056865:0.821554:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.001905:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.001955:0.003639:0.003881:0.003881:0.003881:0.002812:0.003881:0.003881:0.001955:0.001582:0.008880:0.006219:0.003860:0.001925:0.001925:0.003659:0.004082:0.004022:0.003659:0.002359:0.004022:0.001905:0.004385:0.001955:0.001905:0.004556:0.002439:0.003669:0.004082:0.001895:0.003659:0.001905:0.004385:0.001955:0.001905:0.004566:0.003659:0.001925:0.003659:0.004012:0.002439:0.003669:0.004082:0.001905:0.006038:0.001955:0.001905:0.003659:0.002570:0.001905:0.003669:0.001794:0.001955:0.001905:0.002268:0.003860:0.002500:0.001905:0.002570:0.004082:0.003659:0.001905:0.003427:0.004012:0.002359:0.003860:0.004022:0.003659:0.003669:0.004082:0.001552:0.003024:0.003669:0.002913:0.003568:0.001905:0.003276:0.003860:0.002359:0.002983:0.003659:0.001905:0.003860:0.004082:0.001905:0.004264:0.002490:0.003860:0.004022:0.001855:0.003044:0.001905:0.004566:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.002832:0.003568:0.004385:0.004395:0.004243:0.001905:0.003427:0.003044:0.003034:0.003659:0.006249:0.003669:0.001552:0.003024:0.003669:0.002913:0.003568:0.001905:0.003276:0.003860:0.002359:0.002983:0.003558:0.001955:0.001905:0.003568:0.003568:0.003004:0.004385:0.004485:0.002832:0.003568:0.004385:0.004395:0.004243:0.001905:0.003427:0.003044:0.003034:0.003659:0.006249:0.003669:0.001905:0.002570:0.003669:0.002913:0.003568:0.001905:0.002268:0.003860:0.002359:0.002983:0.003659:0.001905:0.003881:0.003881:0.003881:0.003881:0.001905:0.004022:0.003860:0.002913:0.001855:0.002570:0.001855:0.003860:0.004082:0.001905:0.004022:0.003669:0.004022:0.003659:0.002500:0.001905:0.003860:0.004082:0.001905:0.004022:0.001855:0.003669:0.004022:0.004082:0.003860:0.002913:0.001855:0.002913:0.001905:0.003669:0.004082:0.004022:0.001905:0.002570:0.002359:0.003659:0.003578:0.002570:0.006249:0.003659:0.004022:0.002570:0.001905:0.003860:0.002298:0.001905:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001905:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001905:0.001855:0.004082:0.001905:0.003669:0.004022:0.004012:0.001925:0.002570:0.001905:0.003669:0.004082:0.004022:0.001905:0.004022:0.003669:0.003659:0.004022:0.001855:0.003578:0.002570:0.002500:0.001855:0.003044:0.001905:0.004022:0.003578:0.002570:0.001855:0.003659:0.004022:0.002570:0.002782:0.001955:0.001905:0.002671:0.001905:0.003427:0.004012:0.002500:0.001905:0.004284:0.003074:0.003669:0.004022:0.001582
3. :@0.144505:0.830675:0.152750:0.830675:0.152750:0.821377:0.144505:0.821377:0.004294:0.002348:0.001603
Dermatol venereal 2016. DOI: 10.1111/jdv.13599.  Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment (Protopic®). J Dermatol Treatment 2003;14(Suppl 1):5-16.   Kirsner RS, He ernan MP, Antaya R. Safety and E  cacy of Tacrolimus Ointment Versus :@0.056865:0.838372:0.963140:0.838372:0.963140:0.829251:0.056865:0.829251:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.002288:0.003367:0.003659:0.004082:0.003659:0.002359:0.003659:0.003669:0.001925:0.002288:0.003881:0.003881:0.003881:0.003881:0.001955:0.002288:0.004485:0.004495:0.002006:0.001955:0.002288:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.003881:0.002832:0.001895:0.004022:0.003064:0.001955:0.003881:0.003881:0.003881:0.003881:0.003881:0.001955:0.001582:0.009676:0.004102:0.003669:0.004022:0.004022:0.002288:0.004385:0.001955:0.002288:0.004354:0.001925:0.001925:0.003659:0.004082:0.002288:0.004193:0.004122:0.001955:0.002288:0.004122:0.003659:0.001855:0.002570:0.003669:0.006249:0.003860:0.002288:0.003639:0.001955:0.002288:0.004264:0.002490:0.003860:0.004022:0.001855:0.003044:0.002288:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.002288:0.006249:0.003669:0.004082:0.003669:0.004022:0.003659:0.006249:0.003659:0.004022:0.002570:0.002288:0.005705:0.001855:0.002570:0.004082:0.002288:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002288:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.002288:0.002550:0.003961:0.002359:0.003860:0.002490:0.003860:0.004022:0.001855:0.003044:0.003750:0.002550:0.001955:0.002288:0.002671:0.002288:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.001935:0.003024:0.002359:0.003659:0.003578:0.002570:0.006249:0.003659:0.004022:0.002570:0.002288:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.002550:0.003689:0.004012:0.004022:0.004022:0.001925:0.002288:0.003881:0.002550:0.001955:0.003881:0.002812:0.003881:0.003881:0.001955:0.001582:0.007348:0.002288:0.004072:0.001855:0.002500:0.002913:0.004082:0.003659:0.002500:0.002288:0.004122:0.003639:0.001955:0.002288:0.004626:0.003659:0.002258:0.002258:0.003659:0.002500:0.004082:0.003669:0.004082:0.002288:0.006038:0.002641:0.001955:0.002288:0.004354:0.004022:0.002570:0.003568:0.003397:0.003669:0.002288:0.004122:0.001955:0.002288:0.003719:0.003669:0.002268:0.003659:0.002671:0.003487:0.002288:0.003669:0.004082:0.004022:0.002288:0.003467:0.002167:0.002167:0.002167:0.003074:0.003669:0.003246:0.003487:0.002288:0.003860:0.002298:0.001935:0.003024:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002288:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001935:0.003870:0.003659:0.002500:0.002913:0.004012:0.002913:0.001582
4. :@0.214295:0.838372:0.222539:0.838372:0.222539:0.829074:0.214295:0.829074:0.004294:0.002348:0.001603
5.:@0.682370:0.838372:0.689012:0.838372:0.689012:0.829074:0.682370:0.829074:0.004294:0.002348
Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids. Acta Derm Venereol 2010;90:58–64.   Danby SG, Chittock J, Brown K, :@0.056865:0.846069:0.627165:0.846069:0.627165:0.836948:0.056865:0.836948:0.003961:0.001855:0.006249:0.003659:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001976:0.003719:0.002359:0.003659:0.003669:0.006249:0.001976:0.001855:0.004082:0.001976:0.002570:0.004082:0.003659:0.001623:0.003024:0.002359:0.003659:0.003578:0.002570:0.006249:0.003659:0.004022:0.002570:0.001976:0.003860:0.002298:0.001976:0.003770:0.003578:0.002570:0.001855:0.003659:0.004022:0.002570:0.002913:0.001976:0.005705:0.001855:0.002570:0.004082:0.001976:0.004264:0.002490:0.003860:0.004022:0.001855:0.003044:0.001976:0.004566:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001976:0.003961:0.002359:0.003659:0.003498:0.001855:0.003860:0.004012:0.002913:0.001925:0.003487:0.001623:0.003024:0.002359:0.003659:0.003578:0.002490:0.003659:0.004022:0.001976:0.005705:0.001855:0.002570:0.004082:0.001976:0.003578:0.003860:0.002742:0.002570:0.001855:0.002983:0.003860:0.002913:0.002490:0.003659:0.002359:0.003860:0.001855:0.004022:0.002782:0.001955:0.001976:0.004284:0.003195:0.002570:0.003669:0.001976:0.004566:0.003659:0.002500:0.006249:0.001623:0.003870:0.003659:0.004082:0.003659:0.002359:0.003659:0.003860:0.001925:0.001976:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.001955:0.003881:0.003881:0.005040:0.003881:0.003881:0.001955:0.001582:0.007035:0.001976:0.004485:0.003669:0.004082:0.003951:0.003487:0.001976:0.003639:0.004395:0.001955:0.001976:0.003729:0.004082:0.001855:0.002570:0.002490:0.003860:0.003044:0.003568:0.001976:0.002611:0.001955:0.001976:0.004223:0.002359:0.003790:0.005705:0.004082:0.001976:0.004143:0.001955:0.001582
6.:@0.521403:0.846069:0.528045:0.846069:0.528045:0.836771:0.521403:0.836771:0.004294:0.002348
et al,:@0.627558:0.846069:0.642486:0.846069:0.642486:0.836956:0.627558:0.836956:0.003407:0.002419:0.001855:0.003830:0.001492:0.001925
 The e ect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with :@0.642486:0.846069:0.963151:0.846069:0.963151:0.836948:0.642486:0.836948:0.001623:0.003437:0.004082:0.003659:0.001976:0.003659:0.002258:0.002258:0.003659:0.003195:0.002570:0.001976:0.003860:0.002298:0.001976:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001976:0.002983:0.003860:0.006249:0.004022:0.003669:0.002359:0.003659:0.004022:0.001976:0.005705:0.001855:0.002570:0.004082:0.001976:0.004022:0.003659:0.002570:0.003669:0.006249:0.003659:0.002570:0.004082:0.003669:0.002913:0.003860:0.004082:0.003659:0.001976:0.003407:0.003669:0.001925:0.003659:0.002439:0.003578:0.002490:0.003659:0.001976:0.003860:0.004082:0.001976:0.002570:0.004082:0.003659:0.001976:0.002913:0.003528:0.001855:0.004082:0.001976:0.004022:0.003669:0.002500:0.002500:0.001855:0.003659:0.002500:0.001976:0.001855:0.004082:0.001976:0.003367:0.003860:0.001925:0.004012:0.004022:0.002490:0.003659:0.003659:0.002500:0.002913:0.001976:0.005705:0.001855:0.002570:0.004082:0.001582
quiescent atopic dermatitis. Br J Dermat 2014;170:914–921.   Breneman D, Fleischer AB, Abramovits W,:@0.056865:0.853766:0.381108:0.853766:0.381108:0.844645:0.056865:0.844645:0.004022:0.004012:0.001855:0.003659:0.002913:0.002983:0.003659:0.004022:0.002570:0.001794:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001794:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002782:0.001955:0.001794:0.004223:0.002500:0.001794:0.002671:0.001794:0.004566:0.003659:0.002500:0.006249:0.003578:0.002570:0.001794:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.005040:0.003881:0.003881:0.003881:0.001955:0.001582:0.006854:0.001794:0.004223:0.002359:0.003659:0.004082:0.003659:0.006249:0.003669:0.004082:0.001794:0.004062:0.001955:0.001794:0.003377:0.001925:0.003659:0.001855:0.002913:0.003044:0.004082:0.003659:0.002500:0.001794:0.004385:0.004022:0.001955:0.001794:0.004354:0.004022:0.002439:0.003669:0.006249:0.003790:0.003498:0.001855:0.002570:0.002913:0.001441:0.005937:0.001955
7.:@0.245430:0.853766:0.252072:0.853766:0.252072:0.844468:0.245430:0.844468:0.004294:0.002348
et al,:@0.381108:0.853766:0.395864:0.853766:0.395864:0.844653:0.381108:0.844653:0.003407:0.002419:0.001683:0.003830:0.001492:0.001925
 for the Tacrolimus Ointment Study Group. Intermittent therapy for  are prevention and long-term disease control in stabilized atopic dermatitis: A randomized comparison of 3-times-:@0.395864:0.853766:0.961679:0.853766:0.961679:0.844645:0.395864:0.844645:0.001794:0.002268:0.003860:0.002500:0.001794:0.002570:0.004082:0.003659:0.001441:0.003024:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001794:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001794:0.003598:0.002570:0.004012:0.004022:0.003487:0.001794:0.004425:0.002359:0.003860:0.004012:0.003679:0.001955:0.001794:0.002006:0.004022:0.002490:0.003659:0.002500:0.006249:0.001855:0.002570:0.002490:0.003659:0.004022:0.002570:0.001794:0.002570:0.004082:0.003659:0.002439:0.003669:0.003951:0.003487:0.001794:0.002268:0.003860:0.002500:0.001794:0.002107:0.002107:0.003669:0.002359:0.003659:0.001794:0.004022:0.002359:0.003659:0.003367:0.003659:0.004022:0.002570:0.001855:0.003860:0.004082:0.001794:0.003669:0.004082:0.004022:0.001794:0.001925:0.003860:0.004082:0.004022:0.002812:0.002490:0.003659:0.002500:0.006249:0.001794:0.004022:0.001855:0.002913:0.003659:0.003669:0.002913:0.003659:0.001794:0.002983:0.003860:0.004022:0.002570:0.002359:0.003860:0.001925:0.001794:0.001855:0.004082:0.001794:0.002913:0.002570:0.003669:0.004022:0.001855:0.001925:0.001855:0.003034:0.003659:0.004022:0.001794:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001794:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001955:0.001794:0.004385:0.001794:0.002439:0.003669:0.004082:0.004022:0.003860:0.006249:0.001855:0.003034:0.003659:0.004022:0.001794:0.002983:0.003860:0.006249:0.004022:0.003669:0.002500:0.001855:0.002913:0.003860:0.004082:0.001794:0.003860:0.002298:0.001794:0.003881:0.002812:0.002570:0.001855:0.006249:0.003659:0.002913:0.002812
weekly applications of tacrolimus ointment versus vehicle. J Am Acad Dermatol 2008;58:990-9.   Thaçi D, Reitamo S, Gonzalez Ensenat MA, :@0.056865:0.861463:0.483000:0.861463:0.483000:0.852342:0.056865:0.852342:0.005574:0.003659:0.003659:0.003568:0.001925:0.003487:0.001361:0.003669:0.004022:0.004022:0.001925:0.001855:0.003074:0.003578:0.002570:0.001855:0.003860:0.004082:0.002913:0.001361:0.003860:0.002298:0.001361:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001361:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001361:0.003367:0.003659:0.002500:0.002913:0.004012:0.002913:0.001361:0.003367:0.003659:0.004082:0.001855:0.003044:0.001925:0.003558:0.001955:0.001361:0.002671:0.001361:0.004354:0.006249:0.001361:0.004284:0.003074:0.003669:0.004022:0.001361:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.001361:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.002812:0.003881:0.001955:0.001582:0.006421:0.001008:0.003437:0.004082:0.003669:0.003034:0.001855:0.001361:0.004062:0.001955:0.001361:0.004122:0.003659:0.001855:0.002570:0.003669:0.006249:0.003860:0.001361:0.003639:0.001955:0.001361:0.004425:0.003860:0.004082:0.003155:0.003669:0.001925:0.003588:0.003155:0.001361:0.003528:0.004082:0.002913:0.003659:0.004082:0.003578:0.002570:0.001361:0.005967:0.004385:0.001955:0.001582
8.:@0.347352:0.861463:0.353994:0.861463:0.353994:0.852165:0.347352:0.852165:0.004294:0.002348
et al,:@0.482869:0.861463:0.497222:0.861463:0.497222:0.852350:0.482869:0.852350:0.003407:0.002419:0.001280:0.003830:0.001492:0.001925
 for the European Tacrolimus Ointment Study Group. Proactive disease management with 0.03 % tacrolimus ointment for children with atopic dermatitis: :@0.497222:0.861463:0.963130:0.861463:0.963130:0.852342:0.497222:0.852342:0.001361:0.002268:0.003860:0.002500:0.001361:0.002570:0.004082:0.003659:0.001361:0.003427:0.004012:0.002359:0.003860:0.004022:0.003659:0.003669:0.004082:0.001008:0.003024:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001361:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001361:0.003598:0.002570:0.004012:0.004022:0.003487:0.001361:0.004425:0.002359:0.003860:0.004012:0.003679:0.001955:0.001361:0.003961:0.002359:0.003860:0.003669:0.003195:0.002570:0.001855:0.003367:0.003659:0.001361:0.004022:0.001855:0.002913:0.003659:0.003669:0.002913:0.003659:0.001361:0.006249:0.003669:0.004082:0.003669:0.004022:0.003659:0.006249:0.003659:0.004022:0.002570:0.001361:0.005705:0.001855:0.002570:0.004082:0.001361:0.003881:0.001955:0.003881:0.003881:0.001361:0.006501:0.001361:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001361:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001361:0.002268:0.003860:0.002500:0.001361:0.003044:0.004082:0.001855:0.001925:0.004022:0.002359:0.003659:0.004082:0.001361:0.005705:0.001855:0.002570:0.004082:0.001361:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001361:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001955:0.001582
results of a randomized, multicentre, comparative study. Br J Dermatol 2008;159:1348–1356.   Reitamo S, Rustin M, Harper J, :@0.056865:0.869160:0.452147:0.869160:0.452147:0.860039:0.056865:0.860039:0.002359:0.003659:0.002913:0.004012:0.001925:0.002570:0.002913:0.001754:0.003860:0.002298:0.001754:0.003669:0.001754:0.002439:0.003669:0.004082:0.004022:0.003860:0.006249:0.001855:0.003034:0.003659:0.003891:0.001955:0.001754:0.006249:0.004012:0.001925:0.002570:0.001855:0.002983:0.003659:0.004022:0.002570:0.002359:0.003558:0.001955:0.001754:0.002983:0.003860:0.006249:0.004022:0.003669:0.002439:0.003578:0.002570:0.001855:0.003367:0.003659:0.001754:0.002913:0.002570:0.004012:0.004022:0.003054:0.001955:0.001754:0.004223:0.002500:0.001754:0.002671:0.001754:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.001754:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.003881:0.005040:0.003881:0.003881:0.003881:0.003881:0.001955:0.001754:0.001582:0.008628:0.004122:0.003659:0.001855:0.002570:0.003669:0.006249:0.003860:0.001754:0.003639:0.001955:0.001754:0.004122:0.004012:0.002913:0.002570:0.001855:0.004082:0.001754:0.006038:0.001955:0.001754:0.004667:0.003669:0.002500:0.004022:0.003659:0.002500:0.001754:0.002611:0.001955:0.001582
9. :@0.348632:0.869160:0.356877:0.869160:0.356877:0.859862:0.348632:0.859862:0.004294:0.002348:0.001603
et al,:@0.452319:0.869160:0.467034:0.869160:0.467034:0.860047:0.452319:0.860047:0.003407:0.002419:0.001643:0.003830:0.001492:0.001925
 and the 0.1 % Tacrolimus Ointment Long-term Follow-up Study Group. A 4-year follow-up study of atopic dermatitis therapy with 0.1 % tacrolimus ointment in :@0.467034:0.869160:0.963120:0.869160:0.963120:0.860039:0.467034:0.860039:0.001754:0.003669:0.004082:0.004022:0.001754:0.002570:0.004082:0.003659:0.001754:0.003881:0.001955:0.003881:0.001754:0.006501:0.001401:0.003024:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001754:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001754:0.003306:0.003860:0.004082:0.004022:0.002812:0.002490:0.003659:0.002500:0.006249:0.001754:0.003276:0.003860:0.001925:0.001925:0.003790:0.005665:0.002812:0.004012:0.004022:0.001754:0.003598:0.002570:0.004012:0.004022:0.003487:0.001754:0.004425:0.002359:0.003860:0.004012:0.003679:0.001955:0.001754:0.004385:0.001754:0.003881:0.002812:0.003356:0.003659:0.003669:0.002500:0.001754:0.002268:0.003860:0.001925:0.001925:0.003790:0.005665:0.002812:0.004012:0.004022:0.001754:0.002913:0.002570:0.004012:0.004022:0.003487:0.001754:0.003860:0.002298:0.001754:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001754:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001754:0.002570:0.004082:0.003659:0.002439:0.003669:0.003951:0.003487:0.001754:0.005705:0.001855:0.002570:0.004082:0.001754:0.003881:0.001955:0.003881:0.001754:0.006501:0.001754:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.001754:0.003860:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002570:0.001754:0.001855:0.004082:0.001582
children and adult patients. Br J Dermatol 2008;159:942–951. :@0.056865:0.876857:0.249109:0.876857:0.249109:0.867736:0.056865:0.867736:0.003044:0.004082:0.001855:0.001925:0.004022:0.002359:0.003659:0.004082:0.001582:0.003669:0.004082:0.004022:0.001582:0.003669:0.004022:0.004012:0.001925:0.002570:0.001582:0.004022:0.003578:0.002570:0.001855:0.003659:0.004022:0.002570:0.002782:0.001955:0.001582:0.004223:0.002500:0.001582:0.002671:0.001582:0.004566:0.003659:0.002500:0.006249:0.003578:0.002490:0.003860:0.001925:0.001582:0.003881:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.001955:0.003881:0.003881:0.003881:0.005040:0.003881:0.003881:0.003881:0.001955:0.001582
10.:@0.249109:0.876857:0.260045:0.876857:0.260045:0.867559:0.249109:0.867559:0.004294:0.004294:0.002348
 Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis – an emerging concept. Allergy 2009: 64: 276–278. :@0.260045:0.876857:0.611633:0.876857:0.611633:0.867736:0.260045:0.867736:0.001230:0.006219:0.003860:0.001925:0.001925:0.003659:0.004082:0.004022:0.003659:0.002359:0.004022:0.001582:0.004385:0.001955:0.001582:0.004223:0.001855:0.003659:0.004022:0.003659:0.002500:0.001230:0.002852:0.001955:0.001582:0.003961:0.002359:0.003860:0.003669:0.003195:0.002570:0.001855:0.003367:0.003659:0.001582:0.002570:0.004082:0.003659:0.002439:0.003669:0.003951:0.003487:0.001582:0.003860:0.002298:0.001582:0.003578:0.002490:0.003860:0.004022:0.001855:0.003044:0.001582:0.004022:0.003659:0.002500:0.006249:0.003578:0.002570:0.001855:0.002570:0.001855:0.002913:0.001582:0.005040:0.001582:0.003669:0.004082:0.001582:0.003659:0.006249:0.003659:0.002359:0.004022:0.001855:0.004082:0.004022:0.001582:0.002983:0.003860:0.004082:0.002983:0.003659:0.004022:0.002439:0.001955:0.001582:0.004354:0.001925:0.001925:0.003659:0.002359:0.004022:0.003487:0.001582:0.003881:0.003881:0.003881:0.003881:0.001955:0.001582:0.003881:0.003881:0.001955:0.001582:0.003881:0.003881:0.003881:0.005040:0.003881:0.003881:0.003881:0.001955:0.001582
S4 PROTOPIC® 0,03 % Ointment. Each 1 g contains 0,3 mg of tacrolimus as tacrolimus monohydrate (0.03%). Reg. No. A40/13.12/0219.  S4 PROTOPIC® 0intment. Each 1 g contains 1,0 mg of tacrolimus as tacrolimus monohydrate (0.1%). Reg. No.  A40/13.12/0231. Under licence from LEO :@0.057470:0.893459:0.963187:0.893534:0.963187:0.884413:0.057470:0.884338:0.003639:0.004614:0.002167:0.004022:0.004122:0.004253:0.003246:0.004495:0.004022:0.002006:0.003760:0.003750:0.002167:0.003881:0.001955:0.003881:0.003881:0.002167:0.006501:0.002167:0.004556:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002439:0.001955:0.002167:0.003528:0.003669:0.003044:0.004082:0.002167:0.003881:0.002167:0.004022:0.002167:0.002983:0.003860:0.004022:0.002570:0.003669:0.001855:0.004082:0.002913:0.002167:0.003881:0.001955:0.003881:0.002167:0.006249:0.004022:0.002167:0.003860:0.002298:0.002167:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002167:0.003669:0.002913:0.002167:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002167:0.006249:0.003860:0.004082:0.003860:0.003991:0.003356:0.004022:0.002439:0.003578:0.002490:0.003659:0.002167:0.002550:0.003881:0.001955:0.003881:0.003881:0.006501:0.002550:0.001955:0.002167:0.004122:0.003659:0.003800:0.001955:0.002167:0.004647:0.003518:0.001955:0.002167:0.004385:0.003881:0.003881:0.002832:0.003881:0.003881:0.001955:0.003881:0.003881:0.002832:0.003881:0.003881:0.003881:0.003881:0.001955:0.002167:0.002792:0.003639:0.004615:0.002167:0.004022:0.004122:0.004253:0.003246:0.004495:0.004022:0.002006:0.003760:0.003750:0.002167:0.003881:0.001855:0.004022:0.002570:0.006249:0.003659:0.004022:0.002439:0.001955:0.002167:0.003528:0.003669:0.003044:0.004082:0.002167:0.003881:0.002167:0.004022:0.002167:0.002983:0.003860:0.004022:0.002570:0.003669:0.001855:0.004082:0.002913:0.002167:0.003881:0.001955:0.003881:0.002167:0.006249:0.004022:0.002167:0.003860:0.002298:0.002167:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002167:0.003669:0.002913:0.002167:0.002570:0.003669:0.003044:0.002359:0.003860:0.001925:0.001855:0.006249:0.004012:0.002913:0.002167:0.006249:0.003860:0.004082:0.003860:0.003991:0.003356:0.004022:0.002439:0.003578:0.002490:0.003659:0.002167:0.002550:0.003881:0.001955:0.003881:0.006501:0.002550:0.001955:0.002167:0.004122:0.003659:0.003800:0.001955:0.002167:0.004647:0.003518:0.001955:0.002167:0.002167:0.004385:0.003881:0.003881:0.002832:0.003881:0.003881:0.001955:0.003881:0.003881:0.002832:0.003881:0.003881:0.003881:0.003881:0.001955:0.002167:0.004606:0.004082:0.004022:0.003659:0.002500:0.002167:0.001925:0.001855:0.002983:0.003659:0.004082:0.002983:0.003659:0.002167:0.002298:0.002359:0.003860:0.006249:0.002167:0.003467:0.003568:0.004495:-0.810240
Pharmaceutical Products, Ballerup, Denmark. For full prescribing information, refer to the package insert approved by the Medicines Regulatory Authority. 2019013110120330.:@0.056861:0.902516:0.595542:0.902516:0.595542:0.893395:0.056861:0.893395:0.004022:0.004082:0.003669:0.002500:0.006249:0.003669:0.002983:0.003659:0.004012:0.002570:0.001855:0.003074:0.003669:0.001925:0.001582:0.003961:0.002359:0.003860:0.004022:0.004012:0.003195:0.002570:0.002782:0.001955:0.001582:0.004253:0.003669:0.001925:0.001925:0.003659:0.002469:0.004012:0.003679:0.001955:0.001582:0.004566:0.003659:0.004082:0.006249:0.003669:0.002500:0.003639:0.001955:0.001582:0.003276:0.003860:0.002500:0.001582:0.002298:0.004012:0.001925:0.001925:0.001582:0.004022:0.002359:0.003659:0.002913:0.003044:0.002500:0.001855:0.004022:0.001855:0.004082:0.004022:0.001582:0.001855:0.004082:0.002268:0.003860:0.002500:0.006249:0.003578:0.002570:0.001855:0.003860:0.004082:0.001955:0.001582:0.002359:0.003659:0.002268:0.003659:0.002500:0.001582:0.002490:0.003860:0.001582:0.002570:0.004082:0.003659:0.001582:0.004022:0.003669:0.003044:0.003618:0.003669:0.004022:0.003659:0.001582:0.001855:0.004082:0.002913:0.003659:0.002742:0.002570:0.001582:0.003669:0.004022:0.004022:0.002359:0.003790:0.003367:0.003659:0.004022:0.001582:0.003951:0.003487:0.001582:0.002570:0.004082:0.003659:0.001582:0.006038:0.003659:0.004022:0.001855:0.003044:0.001855:0.004082:0.003659:0.002913:0.001582:0.004122:0.003659:0.004022:0.004012:0.001925:0.003578:0.002490:0.003860:0.002762:0.003487:0.001582:0.004324:0.004012:0.002570:0.004082:0.003860:0.002500:0.001855:0.002671:0.003054:0.001955:0.001582:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.003881:0.001955
WITH 4 YEARS SAFETY DATA, PROTOPIC IS A RESPONSIBLE CHOICE*:@0.056865:0.642794:0.755994:0.642794:0.755994:0.616006:0.056865:0.616006:0.020330:0.007294:0.013689:0.015322:0.006396:0.013825:0.005715:0.014288:0.012519:0.014451:0.014506:0.012764:0.006396:0.012764:0.014451:0.012220:0.012519:0.011947:0.013662:0.006396:0.014723:0.012655:0.011893:0.014723:0.004491:0.006396:0.013798:0.013798:0.015050:0.012873:0.015866:0.013798:0.007294:0.012356:0.006396:0.007294:0.012764:0.005470:0.013444:0.006396:0.014506:0.012519:0.012764:0.013580:0.015866:0.015513:0.012764:0.007294:0.014152:0.012356:0.012519:0.006069:0.013254:0.015322:0.015866:0.007294:0.013254:0.012519:0.008791
2,3:@0.756799:0.633508:0.776029:0.633508:0.776029:0.617890:0.756799:0.617890:0.008060:0.003586:0.007584
NOW YOU CAN MAINTAIN CONTROL OF THEIR ECZEMA!:@0.056865:0.617327:0.961706:0.617327:0.961706:0.574310:0.056865:0.574310:0.024910:0.024429:0.031640:0.009046:0.021152:0.025478:0.023817:0.009614:0.019622:0.023206:0.024910:0.010139:0.030329:0.023206:0.011712:0.024910:0.019098:0.023206:0.011712:0.024910:0.009614:0.020059:0.025478:0.024910:0.021982:0.022157:0.025478:0.017918:0.009614:0.025478:0.019622:0.008828:0.021982:0.024604:0.020103:0.011712:0.023293:0.010139:0.020103:0.019360:0.020758:0.020103:0.030329:0.023206:0.010969
THEY DON’T STOP:@0.565122:0.064334:0.941638:0.064334:0.941638:0.010668:0.565122:0.010668:0.027424:0.030695:0.025079:0.027369:0.012812:0.030804:0.031785:0.031077:0.011885:0.025624:0.012812:0.025570:0.025788:0.031785:0.026006
NEITHER SHOULD THEIR :@0.621508:0.086320:0.895943:0.086320:0.895943:0.057909:0.621508:0.057909:0.016452:0.013277:0.007735:0.014518:0.016250:0.013277:0.015384:0.006783:0.013537:0.016250:0.016827:0.015731:0.013104:0.016308:0.006783:0.014518:0.016250:0.013277:0.007735:0.014518:0.005917
ECZEMA TREATMENT!:@0.635247:0.112770:0.876258:0.112770:0.876258:0.084359:0.635247:0.084359:0.013277:0.014057:0.013710:0.013277:0.020031:0.015327:0.006783:0.014518:0.015384:0.013277:0.015327:0.014518:0.020031:0.013277:0.016452:0.014518:0.007245
ALSO INDICATED FOR :@0.095053:0.437386:0.349706:0.437386:0.349706:0.407316:0.095053:0.407316:0.016221:0.013869:0.014327:0.017443:0.007179:0.008187:0.017413:0.017260:0.008187:0.013716:0.014205:0.015366:0.014052:0.016893:0.007179:0.013716:0.017810:0.015366:0.006262
MAINTENANCE THERAPY :@0.076694:0.465379:0.368096:0.465379:0.368096:0.435309:0.076694:0.435309:0.021201:0.016221:0.008187:0.017413:0.015366:0.014052:0.017413:0.016221:0.017413:0.014877:0.014052:0.005376:0.015366:0.017199:0.014052:0.015305:0.016221:0.014785:0.014419:0.006262
OF ATOPIC DERMATITIS:@0.078374:0.493373:0.350745:0.493373:0.350745:0.463303:0.078374:0.463303:0.017810:0.013716:0.006140:0.014205:0.014449:0.017810:0.015488:0.008187:0.013869:0.007179:0.017260:0.014052:0.016282:0.021201:0.014205:0.015366:0.008187:0.015366:0.008187:0.013411
1:@0.351630:0.482949:0.360143:0.482949:0.360143:0.465418:0.351630:0.465418:0.008513
NOW!!:@0.126253:0.408364:0.309206:0.408364:0.309206:0.329655:0.126253:0.329655:0.043179:0.042300:0.057333:0.020070:0.020070
tacrolimus 0.03%,:@0.176871:0.553351:0.279971:0.553351:0.279971:0.531803:0.176871:0.531803:0.003867:0.006620:0.006445:0.004348:0.006620:0.003430:0.003430:0.010247:0.006620:0.006161:0.004085:0.007516:0.002971:0.007516:0.007516:0.012519:0.003190
0.1% ointment:@0.176871:0.567548:0.259586:0.567548:0.259586:0.546000:0.176871:0.546000:0.007516:0.002971:0.007516:0.012519:0.004085:0.006620:0.003430:0.006620:0.003867:0.010247:0.006620:0.006620:0.004085
WITH 4 YEARS SAFETY DATA, PROTOPIC IS A RESPONSIBLE CHOICE*YEARS SAFETY DATA, PROTOPIC IS A RESPONSIBLE CHOICE*:@0.056865:0.642794:0.755994:0.642794:0.755994:0.616006:0.056865:0.616006:0.020330:0.007294:0.013689:0.015322:0.006396:0.013825:0.005715:0.014288:0.012519:0.014451:0.014506:0.012764:0.006396:0.012764:0.014451:0.012220:0.012519:0.011947:0.013662:0.006396:0.014723:0.012655:0.011893:0.014723:0.004491:0.006396:0.013798:0.013798:0.015050:0.012873:0.015866:0.013798:0.007294:0.012356:0.006396:0.007294:0.012764:0.005470:0.013444:0.006396:0.014506:0.012519:0.012764:0.013580:0.015866:0.015513:0.012764:0.007294:0.014152:0.012356:0.012519:0.006069:0.013254:0.015322:0.015866:0.007294:0.013254:0.012519:-0.607768:0.014288:0.012519:0.014451:0.014506:0.012764:0.006396:0.012764:0.014451:0.012220:0.012519:0.011947:0.013662:0.006396:0.014723:0.012655:0.011893:0.014723:0.004491:0.006396:0.013798:0.013798:0.015050:0.012873:0.015866:0.013798:0.007294:0.012356:0.006396:0.007294:0.012764:0.005470:0.013444:0.006396:0.014506:0.012519:0.012764:0.013580:0.015866:0.015513:0.012764:0.007294:0.014152:0.012356:0.012519:0.006069:0.013254:0.015322:0.015866:0.007294:0.013254:0.012519:0.008791
2,3:@0.756799:0.633508:0.776029:0.633508:0.776029:0.617890:0.756799:0.617890:0.008060:0.003586:0.007584
WITH 4 :@0.056865:0.642794:0.139300:0.642794:0.139300:0.616006:0.056865:0.616006:0.020330:0.007294:0.013689:0.015322:0.006396:0.013825:0.005579
2,3:@0.756799:0.633508:0.776029:0.633508:0.776029:0.617890:0.756799:0.617890:0.008060:0.003586:0.007584
Progressive.  Proactive.:@0.622947:0.794869:0.797253:0.794869:0.797253:0.775636:0.622947:0.775636:0.009737:0.006255:0.009195:0.009528:0.006255:0.008945:0.006964:0.006964:0.004858:0.008152:0.008736:0.004858:0.005506:0.003524:0.009737:0.006255:0.009195:0.009007:0.007339:0.006693:0.004858:0.008152:0.008736:0.004858
4:@0.713600:0.787908:0.718778:0.787908:0.718778:0.776695:0.713600:0.776695:0.005178
1,10 :@0.797460:0.787908:0.818246:0.787908:0.818246:0.776695:0.797460:0.776695:0.005300:0.002954:0.005300:0.005300:0.001933
Protective.:@0.818367:0.794869:0.899702:0.794869:0.899702:0.775636:0.818367:0.775636:0.009737:0.006255:0.009195:0.006568:0.008945:0.007339:0.006693:0.004858:0.008152:0.008736:0.004858
2,5,6:@0.899909:0.787908:0.921594:0.787908:0.921594:0.776695:0.899909:0.776695:0.005300:0.002954:0.005300:0.002954:0.005178
11314T PRO Advert.indd   1:@0.026045:1.019244:0.152662:1.019244:0.152662:1.010721:0.026045:1.010721:0.005604:0.005604:0.005604:0.005604:0.005604:0.006158:0.002802:0.006723:0.007277:0.007842:0.002802:0.006723:0.005604:0.005040:0.005604:0.003356:0.002802:0.002802:0.002238:0.005604:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604
2019/05/27   16:30:@0.918531:1.019244:1.002593:1.019244:1.002593:1.010721:0.918531:1.010721:0.005604:0.005604:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604:0.005604:0.002802:0.005604:0.005604